Epigallocatechin 3-gallate ameliorates bile duct ligation induced liver injury in mice by modulation of mitochondrial oxidative stress and inflammation.

PubWeight™: 0.78‹?›

🔗 View Article (PMC 4425400)

Published in PLoS One on May 08, 2015

Authors

Kezhen Shen1, Xiaowen Feng1, Rong Su1, Haiyang Xie1, Lin Zhou1, Shusen Zheng2

Author Affiliations

1: Key Laboratory of Combined Multi-organ Transplantation, Ministry of Public Health, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, China; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, China.
2: Key Laboratory of Combined Multi-organ Transplantation, Ministry of Public Health, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, China; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, China; Division of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Articles cited by this

NF-kappaB: a key role in inflammatory diseases. J Clin Invest (2001) 9.66

Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem (2000) 9.07

Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J Biol Chem (2007) 5.37

Liver transplantation (1). N Engl J Med (1989) 4.53

A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis. Gastroenterology (2004) 2.70

Hepatocyte apoptosis after bile duct ligation in the mouse involves Fas. Gastroenterology (1999) 2.56

Peroxynitrite reactions and formation in mitochondria. Free Radic Biol Med (2002) 2.29

Neutrophils aggravate acute liver injury during obstructive cholestasis in bile duct-ligated mice. Hepatology (2003) 2.00

The major green tea polyphenol, (-)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice. J Nutr (2008) 1.82

STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity. Hepatology (2006) 1.80

Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice. Gastroenterology (2003) 1.79

Loss of signal transducer and activator of transcription 5 leads to hepatosteatosis and impaired liver regeneration. Hepatology (2007) 1.77

Hepatotoxicity of high oral dose (-)-epigallocatechin-3-gallate in mice. Food Chem Toxicol (2009) 1.76

Hepatic stellate cells and liver fibrosis. Compr Physiol (2013) 1.75

The global impact of hepatic fibrosis and end-stage liver disease. Clin Liver Dis (2008) 1.73

Effects of dietary supplementation with epigallocatechin-3-gallate on weight loss, energy homeostasis, cardiometabolic risk factors and liver function in obese women: randomised, double-blind, placebo-controlled clinical trial. Br J Nutr (2013) 1.69

Acetaminophen-induced hepatotoxicity: role of metabolic activation, reactive oxygen/nitrogen species, and mitochondrial permeability transition. Drug Metab Rev (2004) 1.65

Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice. Hepatology (2012) 1.61

Characterization of time-related changes after experimental bile duct ligation. Br J Surg (2008) 1.60

Green tea catechins and cardiovascular health: an update. Curr Med Chem (2008) 1.58

Epigallocatechin-3-gallate (EGCG): chemical and biomedical perspectives. Phytochemistry (2006) 1.53

A single ascending dose study of epigallocatechin gallate in healthy volunteers. J Int Med Res (2003) 1.48

Nitric oxide and peroxynitrite interactions with mitochondria. Biol Chem (2002) 1.48

Beneficial effects of green tea: a literature review. Chin Med (2010) 1.44

Apoptosis and necrosis in liver disease. Liver Int (2004) 1.41

Tumor necrosis factor alpha-dependent up-regulation of Lrh-1 and Mrp3(Abcc3) reduces liver injury in obstructive cholestasis. J Biol Chem (2003) 1.34

Epigallocatechin-3-gallate (EGCG) reduces liver inflammation, oxidative stress and fibrosis in carbon tetrachloride (CCl4)-induced liver injury in mice. Toxicology (2010) 1.30

Poly(ADP-ribose) signaling in cell death. Mol Aspects Med (2013) 1.30

Antioxidant enzyme status in biliary obstructed rats: effects of N-acetylcysteine. J Hepatol (1997) 1.18

Restoration of altered microRNA expression in the ischemic heart with resveratrol. PLoS One (2010) 1.17

Reactive species and mitochondrial dysfunction: mechanistic significance of 4-hydroxynonenal. Environ Mol Mutagen (2010) 1.17

Cellular localization and up-regulation of multidrug resistance-associated protein 3 in hepatocytes and cholangiocytes during obstructive cholestasis in rat liver. Hepatology (2001) 1.16

Polyphenols and mitochondria: an update on their increasingly emerging ROS-scavenging independent actions. Arch Biochem Biophys (2014) 1.13

Role of NADPH oxidases in liver fibrosis. Antioxid Redox Signal (2014) 1.10

Poly (ADP-ribose) polymerase-1 is a key mediator of liver inflammation and fibrosis. Hepatology (2014) 1.09

Epigallocatechin-3-gallate (EGCG) attenuates inflammation in MRL/lpr mouse mesangial cells. Cell Mol Immunol (2010) 1.08

Hepatic inflammation and progressive liver fibrosis in chronic liver disease. World J Gastroenterol (2014) 1.06

Robust protein nitration contributes to acetaminophen-induced mitochondrial dysfunction and acute liver injury. Free Radic Biol Med (2013) 1.05

Green tea epigallocatechin 3-gallate accumulates in mitochondria and displays a selective antiapoptotic effect against inducers of mitochondrial oxidative stress in neurons. Antioxid Redox Signal (2009) 1.04

Matrix metalloproteinases in liver injury, repair and fibrosis. Matrix Biol (2015) 1.03

Ursodeoxycholic acid-induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosis. Hepatology (1990) 1.02

Mitochondrial protein tyrosine nitration. Free Radic Res (2010) 1.02

Modulation of poly(ADP-ribosylation) in apoptotic cells. Biochem Pharmacol (2004) 1.01

Poly(ADP-ribose): a signaling molecule in different paradigms of cell death. Biochem Pharmacol (2014) 1.00

Gadolinium chloride suppresses hepatic oval cell proliferation in rats with biliary obstruction. Am J Pathol (1998) 0.99

Liver stem cells: a two compartment system. Curr Opin Cell Biol (1998) 0.96

Redox proteomic identification of HNE-bound mitochondrial proteins in cardiac tissues reveals a systemic effect on energy metabolism after doxorubicin treatment. Free Radic Biol Med (2014) 0.93

Review of experimental models for inducing hepatic cirrhosis by bile duct ligation and carbon tetrachloride injection. Acta Cir Bras (2012) 0.92

Mitochondrial modulation by Epigallocatechin 3-Gallate ameliorates cisplatin induced renal injury through decreasing oxidative/nitrative stress, inflammation and NF-kB in mice. PLoS One (2015) 0.92

Multifunctional effect of epigallocatechin-3-gallate (EGCG) in downregulation of gelatinase-A (MMP-2) in human breast cancer cell line MCF-7. Life Sci (2008) 0.91

Environmental toxins and Parkinson's disease: putative roles of impaired electron transport chain and oxidative stress. Toxicol Ind Health (2010) 0.91

EGCG attenuates high glucose-induced endothelial cell inflammation by suppression of PKC and NF-κB signaling in human umbilical vein endothelial cells. Life Sci (2013) 0.91

(-)Epigallocatechin-gallate (EGCG) prevents mitochondrial damage in isoproterenol-induced cardiac toxicity in albino Wistar rats: a transmission electron microscopic and in vitro study. Pharmacol Res (2008) 0.89

Protective effect of metalloporphyrins against cisplatin-induced kidney injury in mice. PLoS One (2014) 0.87

Dihydrotestosterone sensitises LNCaP cells to death induced by epigallocatechin-3-Gallate (EGCG) or an IGF-I receptor inhibitor. Prostate (2009) 0.87

Contribution of sinusoidal endothelial liver cells to liver fibrosis: expression of transforming growth factor-beta 1 receptors and modulation of plasmin-generating enzymes by transforming growth factor-beta 1. Hepatology (1993) 0.87

Attenuation of liver ischemia/reperfusion induced apoptosis by epigallocatechin-3-gallate via down-regulation of NF-kappaB and c-Jun expression. J Surg Res (2008) 0.86

Green tea epigallocatechin-3-gallate (EGCG) and other flavonoids reduce Alzheimer's amyloid-induced mitochondrial dysfunction. J Alzheimers Dis (2011) 0.86

Epigallocatechin-3-gallate (EGCG) protects skin cells from ionizing radiation via heme oxygenase-1 (HO-1) overexpression. J Radiat Res (2014) 0.85

High-fat diet decreases activity of the oxidative phosphorylation complexes and causes nonalcoholic steatohepatitis in mice. Dis Model Mech (2014) 0.85

The role of the mitochondrial oxidative stress in the cytotoxic effects of the green tea catechin, (-)-epigallocatechin-3-gallate, in oral cells. Mol Nutr Food Res (2013) 0.84

Apoptosis and necrosis: two types of cell death in alcoholic liver disease. Alcohol Health Res World (1997) 0.84

Effect of epigallocatechin-3-gallate on iron overload in mice with alcoholic liver disease. Mol Biol Rep (2010) 0.84

Epigallocatechin-3-gallate(-)protects Chang liver cells against ethanol-induced cytotoxicity and apoptosis. Basic Clin Pharmacol Toxicol (2007) 0.83

Preventive effect of (-)epigallocatechin-gallate (EGCG) on lysosomal enzymes in heart and subcellular fractions in isoproterenol-induced myocardial infarcted Wistar rats. Chem Biol Interact (2008) 0.83

Dietary supplementation of blueberry juice enhances hepatic expression of metallothionein and attenuates liver fibrosis in rats. PLoS One (2013) 0.83

Adiponectin agonist ADP355 attenuates CCl4-induced liver fibrosis in mice. PLoS One (2014) 0.83

(-)-Epigallocatechin-3-gallate reduces experimental colon injury in rats by regulating macrophage and mast cell. Phytother Res (2010) 0.83

The severity of cholestatic injury is modulated by the genetic background. Shock (2005) 0.82

(-)-Epigallocatechin-3-gallate suppresses liver metastasis of human colorectal cancer. Oncol Rep (2013) 0.80

Epigalocatechin-3-gallate (EGCG) downregulates PEA15 and thereby augments TRAIL-mediated apoptosis in malignant glioma. Neurosci Lett (2008) 0.79

The therapeutic effects of EGCG on vitiligo. Fitoterapia (2014) 0.78

Ischemic preconditioning improves liver tolerance to congestion-reperfusion injury in mice. J Surg Res (2014) 0.78

Effects of polyphenols on brain ageing and Alzheimer's disease: focus on mitochondria. Mol Neurobiol (2012) 0.78

Epigallocatechin-3-gallate inhibits tax-dependent activation of nuclear factor kappa B and of matrix metalloproteinase 9 in human T-cell lymphotropic virus-1 positive leukemia cells. Asian Pac J Cancer Prev (2014) 0.78

Vitamin K1 attenuates bile duct ligation-induced liver fibrosis in rats. Scand J Gastroenterol (2014) 0.78

Nitration/S-nitrosation of proteins by peroxynitrite-treatment and subsequent modification by glutathione S-transferase and glutathione peroxidase. Mol Cell Biochem (2002) 0.78

[Cellular mechanism in the fibrogenesis of liver fibrosis]. Zhonghua Gan Zang Bing Za Zhi (2012) 0.76

Differential hepatic protein tyrosine nitration of mouse due to aging - effect on mitochondrial energy metabolism, quality control machinery of the endoplasmic reticulum and metabolism of drugs. Biochem Biophys Res Commun (2012) 0.75